Article
Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy.
Journal of virology - 1 Aug 1999
Pawlotsky J M, Germanidis G, Frainais P O, Bouvier M, Soulier A, Pellerin M, Dhumeaux D
Abstract excerpt
Sustained hepatitis C virus (HCV) RNA clearance is achieved in 8 to 12% of patients with chronic HCV infection treated with alpha interferon (IFN-alpha) at the approved dose of 3 MU three times a week for 6 months and in about 25% of those receiving this treatment for 12 months. We used single-strand conformation polymorphism analysis combined with cloning and sequencing strategies to characterize the genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
